Maple, that is exactly my sentiment....they already have a buyer and have been working on a deal (ie. lack of promotion and filling two significant positions), cash should have been raised a year out in my view and wasn't, why.....The science is proving itself and if continues, can make a significant impact for patients as well as the cost to markets and insurance companies......interim CEO or not ...... a company should be promoting itself unless they are in negotiations with one player who has asked to only do the minimum to not invite other players....so just meet reporting requirements.....I'm sure some will call me crazy but that's ok
News 
Market Data 
Discover 
AI
